Biogen
AGREEMENT GRADE
f
Fortune 500 Rank
OWLER CEO APPROVAL RATING
48/100
GLASSDOOR RATING
3.8
CEO
Christopher A. Viehbacher
Biogen Inc. (previously known as Biogen Idec) is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide.
AG Sources
All disputes arising under or in connection with this Agreement shall be resolved by binding arbitration, to be held in Boston, Massachusetts in accordance with the rules and procedures of the American Arbitration Association.-James Mullen Employee Agreement (2003)
Links